regulation
FDA Urges AI Device Manufacturers for Transparency in Testing Data
NeelRatan
The FDA is enhancing oversight of AI medical devices, advocating for manufacturers to disclose more testing and performance details. New guidance emphasizes early engagement with sponsors and addresses potential risks associated with AI technologies in clinical settings.
Lawmakers Seek Protections Against AI Risks for Marginalized Communities
NeelRatan
Lawmakers are focusing on preventing artificial intelligence from negatively impacting marginalized communities. A bipartisan House Task Force has released a report detailing 66 findings and 85 recommendations aimed at regulating AI innovation responsibly while addressing potential social inequities.
